Concepedia

Publication | Closed Access

Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer

DOI

84

Citations

29

References

2015

Year

Tetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, Wolfgang Jäger, Igor Moskalev, Shannon Awrey, Takashi Dejima, Tilman Todenhöfer, Na Li, Ladan Fazli,
The Journal of Urology

Abstract

T-DM1 has promising antitumor effects in preclinical models of HER2 over expressing bladder cancer.

References

YearCitations

Page 1